230 related articles for article (PubMed ID: 19690031)
1. Evaluation of the role of hexokinase type II in cellular proliferation and apoptosis using human hepatocellular carcinoma cell lines.
Ahn KJ; Hwang HS; Park JH; Bang SH; Kang WJ; Yun M; Lee JD
J Nucl Med; 2009 Sep; 50(9):1525-32. PubMed ID: 19690031
[TBL] [Abstract][Full Text] [Related]
2. The importance of acetyl coenzyme A synthetase for 11C-acetate uptake and cell survival in hepatocellular carcinoma.
Yun M; Bang SH; Kim JW; Park JY; Kim KS; Lee JD
J Nucl Med; 2009 Aug; 50(8):1222-8. PubMed ID: 19617323
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma.
Paudyal B; Oriuchi N; Paudyal P; Tsushima Y; Higuchi T; Miyakubo M; Ishikita T; Nakajima T; Endo K
Ann Nucl Med; 2008 Jan; 22(1):83-6. PubMed ID: 18250992
[TBL] [Abstract][Full Text] [Related]
4. Stunning and its effect on 3H-FDG uptake and key gene expression in breast cancer cells undergoing chemotherapy.
Engles JM; Quarless SA; Mambo E; Ishimori T; Cho SY; Wahl RL
J Nucl Med; 2006 Apr; 47(4):603-8. PubMed ID: 16595493
[TBL] [Abstract][Full Text] [Related]
5. 2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II.
Ong LC; Jin Y; Song IC; Yu S; Zhang K; Chow PK
Acta Radiol; 2008 Dec; 49(10):1145-53. PubMed ID: 18979289
[TBL] [Abstract][Full Text] [Related]
6. Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increased (18)F-FDG uptake.
Lee JD; Yang WI; Park YN; Kim KS; Choi JS; Yun M; Ko D; Kim TS; Cho AE; Kim HM; Han KH; Im SS; Ahn YH; Choi CW; Park JH
J Nucl Med; 2005 Oct; 46(10):1753-9. PubMed ID: 16204727
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro.
Seo S; Hatano E; Higashi T; Nakajima A; Nakamoto Y; Tada M; Tamaki N; Iwaisako K; Kitamura K; Ikai I; Uemoto S
Int J Oncol; 2009 May; 34(5):1303-12. PubMed ID: 19360342
[TBL] [Abstract][Full Text] [Related]
8. Combined RNA interference of hexokinase II and (131)I-sodium iodide symporter gene therapy for anaplastic thyroid carcinoma.
Kim JE; Ahn BC; Hwang MH; Jeon YH; Jeong SY; Lee SW; Lee J
J Nucl Med; 2011 Nov; 52(11):1756-63. PubMed ID: 21994409
[TBL] [Abstract][Full Text] [Related]
9. Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor.
Zhao S; Kuge Y; Mochizuki T; Takahashi T; Nakada K; Sato M; Takei T; Tamaki N
J Nucl Med; 2005 Apr; 46(4):675-82. PubMed ID: 15809491
[TBL] [Abstract][Full Text] [Related]
10. Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma.
Paudyal B; Paudyal P; Oriuchi N; Tsushima Y; Nakajima T; Endo K
Int J Oncol; 2008 Nov; 33(5):1047-54. PubMed ID: 18949368
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide stimulates 18F-FDG uptake in human endothelial cells through increased hexokinase activity and GLUT1 expression.
Paik JY; Lee KH; Ko BH; Choe YS; Choi Y; Kim BT
J Nucl Med; 2005 Feb; 46(2):365-70. PubMed ID: 15695798
[TBL] [Abstract][Full Text] [Related]
12. Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture.
Aloj L; Caracó C; Jagoda E; Eckelman WC; Neumann RD
Cancer Res; 1999 Sep; 59(18):4709-14. PubMed ID: 10493529
[TBL] [Abstract][Full Text] [Related]
13. Fructose-1,6-Bisphosphatase 1 Reduces
Chen R; Li J; Zhou X; Liu J; Huang G
Radiology; 2017 Sep; 284(3):844-853. PubMed ID: 28387640
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of [18F]fluorodeoxyglucose accumulation in liver cancer.
Izuishi K; Yamamoto Y; Mori H; Kameyama R; Fujihara S; Masaki T; Suzuki Y
Oncol Rep; 2014 Feb; 31(2):701-6. PubMed ID: 24297035
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms related to [18F]fluorodeoxyglucose uptake of human colon cancers transplanted in nude mice.
Chung JK; Lee YJ; Kim C; Choi SR; Kim M; Lee K; Jeong JM; Lee DS; Jang JJ; Lee MC
J Nucl Med; 1999 Feb; 40(2):339-46. PubMed ID: 10025844
[TBL] [Abstract][Full Text] [Related]
16. Regulation of uptake of 18F-FDG by a follicular human thyroid cancer cell line with mutation-activated K-ras.
Prante O; Maschauer S; Fremont V; Reinfelder J; Stoehr R; Szkudlinski M; Weintraub B; Hartmann A; Kuwert T
J Nucl Med; 2009 Aug; 50(8):1364-70. PubMed ID: 19652218
[TBL] [Abstract][Full Text] [Related]
17. Expression of hexokinase II and Glut-1 in untreated human breast cancer.
Brown RS; Goodman TM; Zasadny KR; Greenson JK; Wahl RL
Nucl Med Biol; 2002 May; 29(4):443-53. PubMed ID: 12031879
[TBL] [Abstract][Full Text] [Related]
18. Fibronectin stimulates endothelial cell 18F-FDG uptake through focal adhesion kinase-mediated phosphatidylinositol 3-kinase/Akt signaling.
Paik JY; Ko BH; Jung KH; Lee KH
J Nucl Med; 2009 Apr; 50(4):618-24. PubMed ID: 19289426
[TBL] [Abstract][Full Text] [Related]
19. Enhanced antiproliferative effects of combination hexokinase II shRNA and NIS gene therapy on vascular smooth muscle cells.
Hwang MH; Lee SW; Kim JE; Lee HW; Jeon YH; Ha JH; Ahn BC; Lee J
Nucl Med Biol; 2012 Feb; 39(2):269-78. PubMed ID: 21958856
[TBL] [Abstract][Full Text] [Related]
20. Changes in glucose metabolism and gene expression after transfer of anti-angiogenic genes in rat hepatoma.
Haberkorn U; Hoffend J; Schmidt K; Altmann A; Bonaterra GA; Dimitrakopoulou-Strauss A; Strauss LG; Eisenhut M; Kinscherf R
Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2011-23. PubMed ID: 17701172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]